Loading basket contents...
Arthropod-Borne Viruses EQA/PT Scheme
The Arthropod-borne virus EQA will focus on the molecular detection and determination of different arthropod-borne viruses (including viruses from Flavi-, Toga-, Bunya-, and/or Reoviridae families). The panel is designed to represent various clinical scenarios (fever, haemorrhagic symptoms and/or neurological illness) and may include medically important arboviruses such as tick-borne encephalitis viruses, sandfly fever viruses, Japanese encephalitis viruses, Rift Valley fever viruses, or Usutu virus. Participating laboratories will be expected to test each panel using their appropriate molecular methods and report their individual test results to QCMD.
Total Number of Challenges: 1
Number of Panel Members: 10
Distribution / Testing Period: Q3
| Sample NA Target Source | Cultured and/or Clinical material |
| Matrix Panel Format | Transport Medium |
| Panel Member Target Range | Covering clinical range |
| Panel Member Sample Volume | Lyophilised |
| Panel Sample Pre-treatment Requirement | Reconstitution of lyophilised material. |
| Panel Analysis Type | Qualitative. Quantitative for information purposes only |
| Panel Testing | Evaluated by various molecular methodologies |
| Storage / Shipment Conditions | 2-8°C / Lyophilised Ambient |
| Accreditation / Regulatory Status | Accredited to ISO 17043 |
$1,277.43